Free Trial

Genmab A/S (GNMSF) Short Interest Ratio & Short Volume

Genmab A/S logo
$222.23 0.00 (0.00%)
As of 08/1/2025

Genmab A/S Short Interest Data

Genmab A/S (GNMSF) has a short interest of 69,900 shares. This marks a -16.09% decrease in short interest from the previous month. The short interest ratio (days to cover) is 699.0, indicating that it would take 699.0 days of the average trading volume of 31 shares to cover all short positions.

Current Short Interest
69,900 shares
Previous Short Interest
83,300 shares
Change Vs. Previous Month
-16.09%
Dollar Volume Sold Short
$15.03 million
Short Interest Ratio
699.0 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
66,075,000 shares
Percentage of Shares Shorted
0.11%
Today's Trading Volume
0 shares
Average Trading Volume
31 shares
Today's Volume Vs. Average
0%
Short Selling Genmab A/S?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Genmab A/S and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GNMSF Short Interest Over Time

GNMSF Days to Cover Over Time

GNMSF Percentage of Float Shorted Over Time

Genmab A/S Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202569,900 shares $15.03 million -16.1%N/A699 $214.95
6/30/202583,300 shares $17.58 million +86.4%0.1%833 $211.09
6/15/202544,700 shares $10.03 million -62.1%0.1%111.8 $224.30
5/31/2025117,900 shares $24.49 million -19.4%0.2%1179 $207.75
5/15/2025146,300 shares $27.62 million +98.0%0.2%43 $188.80
4/30/202573,900 shares $15.15 million +1.2%N/A246.3 $204.98
4/15/202573,000 shares $13.91 million +30.1%0.1%4.3 $190.50
3/31/202556,100 shares $10.65 million +3.9%0.1%561 $189.80
3/15/202554,000 shares $11.28 million -11.6%0.1%180 $208.89
2/28/202561,100 shares $13.75 million -23.5%0.1%203.7 $224.97
2/15/202579,900 shares $16.86 million -1.2%0.1%21.6 $210.97
1/31/202580,900 shares $15.97 million -20.5%N/A3.8 $197.44
1/15/2025101,800 shares $20.57 million -16.6%N/A28.3 $202.06
12/31/2024122,000 shares $25.30 million +2.3%N/A16.9 $207.38
12/15/2024119,300 shares $23.98 million +9.5%N/A26.5 $201.00
11/30/2024109,000 shares $23.16 million +2.8%N/A7.2 $212.50
11/15/2024106,000 shares $22.55 million +38.9%N/A6.6 $212.71
10/31/202476,300 shares $16.67 million -10.1%N/A4.7 $218.47
10/15/202484,900 shares $19.93 million -19.1%N/A6.7 $234.80
9/30/2024104,900 shares $24.61 million -50.8%N/A80.7 $234.65
9/15/2024213,000 shares $55.32 million +3.3%N/A142 $259.72
8/31/2024206,200 shares $56.67 million +11.1%N/A114.6 $274.83
8/15/2024185,600 shares $49.24 million -1.2%N/A44.2 $265.28
7/31/2024187,900 shares $52.13 million +4.0%N/A19.4 $277.44
7/15/2024180,700 shares $46.58 million +19.5%N/A106.3 $257.77
6/30/2024151,200 shares $37.12 million +28.2%N/A116.3 $245.49
6/15/2024117,900 shares $30.47 million -0.6%N/A107.2 $258.44
5/31/2024118,600 shares $32.69 million +9.0%N/A107.8 $275.67
5/15/2024108,800 shares $31.72 million -49.4%N/A181.3 $291.54
4/30/2024214,900 shares $58.93 million +26.6%N/A126.4 $274.22
4/15/2024169,700 shares $47.86 million +7.3%N/A169.7 $282.00
3/31/2024158,100 shares $48.47 million -3.5%N/A175.7 $306.59
3/15/2024163,800 shares $49.40 million -4.1%N/A136.5 $301.60
2/29/2024170,800 shares $47.55 million +24.1%N/A27.5 $278.41
2/15/2024137,600 shares $39.55 million -11.6%N/A86 $287.40
1/15/202430,700 shares $9.65 million -4.7%N/A16.2 $314.40
12/31/202332,200 shares $10.17 million -1.5%N/A16 $315.70
12/15/202332,700 shares $10.19 million +1.6%N/A12.1 $311.50
11/30/202332,200 shares $10.27 million -42.7%N/A16.9 $319.00
11/15/202356,200 shares $18.21 million +102.2%N/A25.5 $324.07
One stock to replace Nvidia (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
10/31/202327,800 shares $7.98 million +1.1%N/A23.2 $287.10
10/15/202327,500 shares $8.77 million +10.0%N/A45.8 $319.00
9/30/202325,000 shares $8.91 million +113.7%N/A41.7 $356.30
9/15/202311,700 shares $4.40 million -0.9%N/A7.8 $376.20
8/31/202311,800 shares $4.47 million +6.3%N/A15.6 $379.20
8/15/202311,100 shares $4.09 million -31.5%N/A27.8 $368.40
7/31/202316,200 shares $6.65 million -38.2%N/A23.1 $410.40
7/15/202326,200 shares $10.36 million -36.7%N/A18.7 $395.43
6/30/202341,400 shares $15.51 million +19.7%N/A37.6 $374.57
6/15/202334,600 shares $13.30 million -5.5%N/A38.4 $384.50
5/31/202336,600 shares $14.46 million -42.6%N/A73.2 $394.99
5/15/202363,800 shares $27.06 million +69.2%N/A91.1 $424.10
4/30/202337,700 shares $15.41 million -37.5%N/A75.4 $408.70
4/15/202360,300 shares $24.87 million -28.4%N/A67 $412.50
3/31/202384,200 shares $31.47 million -18.7%N/A210.5 $373.75
3/15/2023103,600 shares $36.80 million +143.2%N/A172.7 $355.25
2/28/202342,600 shares $15.90 million -56.0%N/A60.9 $373.25
2/15/202396,900 shares $38.21 million +8.8%N/A193.8 $394.30
1/31/202389,100 shares $34.93 million -3.3%N/A148.5 $392.00
1/15/202392,100 shares $37.12 million +37.3%N/A153.5 $403.00
12/30/202267,100 shares $28.69 million +527.1%N/A41.9 $427.50
12/15/202210,700 shares $4.77 million +78.3%N/A3.8 $445.52
11/30/20226,000 shares $2.75 million -25.0%N/A10 $457.50
11/15/20228,000 shares $3.38 million +14.3%N/A6.7 $422.43
10/31/20227,000 shares $2.69 million -51.7%N/A0.8 $384.30
10/15/202214,500 shares $5.35 million +20.8%N/A11.2 $368.80
9/30/202212,000 shares $3.84 million +10.1%N/A10.9 $320.21
9/15/202210,900 shares $3.88 million -71.7%N/A7.8 $356.25
8/31/202238,500 shares $13.59 million -31.0%N/A55 $353.01
8/15/202255,800 shares $20.85 million +30.1%N/A27.9 $373.61
7/31/202242,900 shares $14.95 million +257.5%N/A39 $348.50
7/15/202212,000 shares $4.09 million -87.2%N/A7.1 $341.16
6/30/202294,000 shares $30.58 million -30.0%N/A16.2 $325.29
6/15/2022134,200 shares $36.61 million +63.7%N/A63.9 $272.80
5/31/202282,000 shares $24.77 million -60.0%N/A8 $302.08
5/15/2022204,900 shares $59.57 million +7.1%N/A113.8 $290.75
4/30/2022191,300 shares $69.71 million +92.7%N/A273.3 $364.42
4/15/202299,300 shares $36.64 million +95.9%N/A66.2 $368.95
3/31/202250,700 shares $18.10 million -4.7%N/A56.3 $357.10
3/15/202253,200 shares $18.22 million -23.8%N/A44.3 $342.42
2/28/202269,800 shares $23.25 million +13.1%N/A34.9 $333.03
2/15/202261,700 shares $20.30 million +5.5%N/A26.8 $328.98
1/31/202258,500 shares $20.03 million +290.0%N/A26.6 $342.38
1/15/202215,000 shares $5.16 million -38.3%N/A10 $344.28
12/31/202124,300 shares $9.49 million -66.7%N/A24.3 $390.53
12/15/202172,900 shares $27.46 million +74.0%N/A11.4 $376.72
11/30/202141,900 shares $15.97 million -17.8%N/A41.9 $381.08
11/15/202151,000 shares $21.14 million +351.3%N/A85 $414.58
10/29/202111,300 shares $5.09 million -33.5%N/A7.1 $450.50
10/15/202117,000 shares $7.60 million +33.9%N/A24.3 $446.95
One stock to replace Nvidia (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
9/30/202112,700 shares $5.37 million -11.8%N/A25.4 $423.08
9/15/202114,400 shares $6.08 million +25.2%N/A13.1 $422.08
8/31/202111,500 shares $5.49 million +0.9%N/A28.8 $477.57
8/13/202111,400 shares $5.18 million +22.6%N/A16.3 $454.38
7/30/20219,300 shares $4.17 million +34.8%N/A5.2 $448.87
7/15/20216,900 shares $3.03 million -13.8%N/A11.5 $438.47
6/30/20218,000 shares $3.38 million -31.6%N/A6.7 $422.32
6/15/202111,700 shares $5.10 million -58.4%N/A14.6 $435.68
5/28/202128,100 shares $11.52 million -64.5%N/A56.2 $409.92
5/14/202179,100 shares $29.48 million -26.7%N/A197.8 $372.72
4/30/2021107,900 shares $40.45 million +6.6%N/A269.8 $374.92
4/15/2021101,200 shares $35.77 million +19.8%N/A44 $353.50
3/31/202184,500 shares $26.73 million +14.8%N/A24.9 $316.28
3/15/202173,600 shares $23.74 million +46.0%N/A73.6 $322.50
2/26/202150,400 shares $17.39 million -40.1%N/A16.8 $345.00
2/12/202184,100 shares $34.26 million +557.0%N/A120.1 $407.32
1/29/202112,800 shares $5.26 million +12.3%N/A8 $411.00
1/15/202122,900 shares $10.04 million +97.4%N/A45.8 $438.42
12/31/202029,700 shares $12.01 million +29.7%N/A74.3 $404.45
12/15/202022,900 shares $8.95 million +97.4%N/A45.8 $390.69
11/30/202011,600 shares $4.35 million -11.5%N/A9.7 $375.01
11/15/202013,100 shares $4.81 million +13.9%N/A14.6 $366.96
10/30/202011,500 shares $3.98 million No ChangeN/A12.8 $346.21
10/15/202011,500 shares $4.43 million -35.0%N/A38.3 $385.31
9/30/202017,700 shares $6.50 million -80.7%N/A14.8 $367.16
9/15/202091,800 shares $34.27 million +37.2%N/A76.5 $373.30
8/31/202066,900 shares $25.24 million +5.5%N/A47.8 $377.29
8/14/202063,400 shares $23.14 million -11.3%N/A52.8 $365.04

GNMSF Short Interest - Frequently Asked Questions

What is Genmab A/S's current short interest?

Short interest is the volume of Genmab A/S shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 69,900 shares of GNMSF short. Learn More on Genmab A/S's current short interest.

What is a good short interest ratio for Genmab A/S?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GNMSF shares currently have a short interest ratio of 699.0. Learn More on Genmab A/S's short interest ratio.

Is Genmab A/S's short interest increasing or decreasing?

Genmab A/S saw a decrease in short interest in the month of July. As of July 15th, there was short interest totaling 69,900 shares, a decrease of 16.1% from the previous total of 83,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Genmab A/S's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Genmab A/S: Daiichi Sankyo Co., Ltd. - Sponsored ADR (0.00%), Takeda Pharmaceutical Co. (0.14%), argenex SE (2.94%), BioNTech SE Sponsored ADR (2.55%), Summit Therapeutics PLC (3.85%), Insmed, Inc. (5.11%), Teva Pharmaceutical Industries Ltd. (4.66%), Genmab A/S Sponsored ADR (0.60%), Moderna, Inc. (19.34%), Dr. Reddy's Laboratories Ltd (1.46%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Genmab A/S stock?

Short selling GNMSF is an investing strategy that aims to generate trading profit from Genmab A/S as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Genmab A/S?

A short squeeze for Genmab A/S occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNMSF, which in turn drives the price of the stock up even further.

How often is Genmab A/S's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNMSF, twice per month. The most recent reporting period available is July, 15 2025.




This page (OTCMKTS:GNMSF) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners